{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:31:54Z","timestamp":1789975914780,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5297,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1046\/j.1523-1747.2001.01363.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:58:56Z","timestamp":1047448736000},"page":"891-897","source":"Crossref","is-referenced-by-count":144,"title":["HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are Related to Disease Activity and are Predominantly Directed Against MelanA\/MART1"],"prefix":"10.1016","volume":"116","author":[{"given":"Karl Sebastian","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Muhm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Moris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Rammensee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze Charlotte","family":"Caroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Wernet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schittek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Knauss-Scherwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma [see comments]","volume":"113","author":"Becker","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0020","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.4049\/jimmunol.147.12.4047","article-title":"The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2","volume":"147","author":"Bednarek","year":"1991","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1084\/jem.181.1.363","article-title":"Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes","volume":"181","author":"Castelli","year":"1995","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-4362.1996.tb00654.x","article-title":"Vitiligo associated with metastatic malignant melanoma","volume":"35","author":"Cavallari","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-0749.1996.tb00098.x","article-title":"Vitiligo, psoralen, and melanogenesis: some observations and understanding","volume":"9","author":"Chakraborty","year":"1996","journal-title":"Pigment Cell Res"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.180.1.35","article-title":"A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas [see comments]","volume":"180","author":"Coulie","year":"1994","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0045","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1126\/science.7513441","article-title":"Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines","volume":"264","author":"Cox","year":"1994","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1991.tb00383.x","article-title":"Prolonged survival in metastatic malignant melanoma associated with vitiligo","volume":"16","author":"Duhra","year":"1991","journal-title":"Clin Exp Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"van Elsas","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1461::AID-CNCR3>3.0.CO;2-E","article-title":"Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo","volume":"79","author":"Fishman","year":"1997","journal-title":"Cancer"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0070","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1744-313X.1995.tb00232.x","article-title":"Study of HLA class I\/IL and T lymphocyte subsets in Kuwaiti vitiligo patients","volume":"22","author":"al-Fouzan","year":"1995","journal-title":"Eur J Immunogenet"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(96)90490-9","article-title":"Cytomegalovirus DNA identified in skin biopsy specimens of patients with vitiligo","volume":"35","author":"Grimes","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3349\/ymj.1995.36.5.457","article-title":"Detection of antibodies to human melanoma cell in vitiligo by western blot analysis","volume":"36","author":"Hann","year":"1995","journal-title":"Yonsei Med J"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1346-8138.1996.tb03978.x","article-title":"Detection of antibodies to human melanoma cells in vitiligo and alopecia areata by Western blot analysis","volume":"23","author":"Hann","year":"1996","journal-title":"J Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0090","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.1546328","article-title":"Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry [see comments]","volume":"255","author":"Hunt","year":"1992","journal-title":"Science"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0095","first-page":"4446","article-title":"Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis","volume":"60","author":"Jenne","year":"2000","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.180.1.347","article-title":"Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes","volume":"180","author":"Kawakami","year":"1994","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0105","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.154.8.3961","article-title":"Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression","volume":"154","author":"Kawakami","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000247568","article-title":"Vitiligo-like depigmentation and morpheas after specific intralymphatic immunotherapy for malignant melanoma","volume":"184","author":"Lacour","year":"1992","journal-title":"Dermatology"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0115","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0120","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/9525","article-title":"Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients","volume":"5","author":"Lee","year":"1999","journal-title":"Nat Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0125","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1128\/JVI.67.12.7428-7435.1993","article-title":"HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2","volume":"67","author":"Lee","year":"1993","journal-title":"J Virol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1346-8138.1998.tb02472.x","article-title":"Peripheral T-cell activation in non-segmental vitiligo","volume":"25","author":"Mahmoud","year":"1998","journal-title":"J Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0135","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0190-9622(90)70029-H","article-title":"T cell subpopulations in vitiligo: a chronobiologic study","volume":"22","author":"Mozzanica","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0145","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/1523-1747.ep12522891","article-title":"Detection of antibodies to melanocytes in vitiligo by specific immunoprecipitation","volume":"81","author":"Naughton","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells [see comments]","volume":"4","author":"Nestle","year":"1998","journal-title":"Nat Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0155","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0160","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","article-title":"Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity","volume":"90","author":"Norris","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0170","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes","volume":"96","author":"Overwijk","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0175","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1084\/jem.190.5.705","article-title":"High frequencies of naive Melan-A\/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA) -A2 individuals","volume":"190","author":"Pittet","year":"1999","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0180","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.4049\/jimmunol.159.5.2366","article-title":"Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A\/MART-1 antigenic peptide in melanoma","volume":"159","author":"Romero","year":"1997","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0190","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4049\/jimmunol.152.4.1702","article-title":"Resistance to natural killer cell lysis conferred by TAP1\/2 genes in human antigen-processing mutant cells","volume":"152","author":"Salcedo","year":"1994","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0195","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.183.2.527","article-title":"An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins","volume":"183","author":"Skipper","year":"1996","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0200","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1084\/jem.185.9.1605","article-title":"Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response","volume":"185","author":"Steven","year":"1997","journal-title":"J Exp Med"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0205","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0210","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/viro.1996.0277","article-title":"Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1","volume":"219","author":"White","year":"1996","journal-title":"Virology"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0215","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/JVI.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp 65: frequency, specificity, and T-cell receptor usage of pp 65-specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J Virol"},{"key":"10.1046\/j.1523-1747.2001.01363.x_bb0220","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830240340","article-title":"Meyer zBKH, Boon T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes","volume":"24","author":"Wolfel","year":"1994","journal-title":"Eur J Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1541262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X1541262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T19:47:27Z","timestamp":1704311247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X1541262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0022202X1541262X"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01363.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}